Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Gobin, Y Pierre ^a   Dunkel, Ira J ^b   Marr, Brian P ^b   Francis, Jasmine H ^b   Brodie, Scott E ^c   Abramson, David H ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; TOPOTECAN;

ANEMIA; ARTICLE; BALLOON OCCLUSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CRYOTHERAPY; ELECTRORETINOGRAPHY; ENUCLEATION; ERYTHEMA; ERYTHROCYTE TRANSFUSION; EYELASH; FEMALE; FOLLOW UP; HUMAN; INFANT; INTERNAL CAROTID ARTERY; LOW LEVEL LASER THERAPY; MALE; MENINGEAL ARTERY; MIDDLE MENINGEAL ARTERY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NEWBORN; OPHTHALMIC ARTERY; PTOSIS; RADIATION FREE SURVIVAL; RETINOBLASTOMA; SIDE EFFECT; SURVIVAL; THROMBOCYTOPENIA; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR REGRESSION; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INTRAVENOUS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRA-ARTERIAL; MALE; RETINAL NEOPLASMS; RETINOBLASTOMA; TREATMENT OUTCOME;

CHAMAESARACHA;

EID: 84866509736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044322     Document Type: Article

References (26)

1. Abramson D, Notterman R, Ellsworth R, Kitchin F, (1983) Retinoblastoma treated in the first six months of life. Arch Ophthalmol 101: 1362-1366.
2. Abramson D, Servodidio C, (1992) Retinoblastoma in the first year of life. Ophthalmic Paediatr Genet 13: 191-203.
3. Abramson DH, Beaverson KL, Chang ST, Dunkel IJ, McCormick B, (2004) Outcome following initial beam radiotherapy in patients with Reese-Ellsworth group 5b retinoblastoma. Arch Ophthalmol 122: 1316-1323.
4. Abramson DH, Frank CM, (1998) Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 105: 573-579.
5. Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, et al. (2009) Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer 45: 3245-3253.
6. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP, (2008) A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115: 1398-1404.
7. Brodie SE, Gobin YP, Dunkel IJ, Kim JW, Abramson DH, (2009) Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 119: 13-22.
8. Abramson DH, Dunkel IJ, Brodie SE, Marr BP, Gobin YP, (2010) Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol 128: 370-372.
9. Abramson DH, Dunkel IJ, Brodie SE, Marr BP, Gobin YP, (2010) Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 117: 1623-1629.
10. Marr BP, Gobin YP, Dunkel IJ, Brodie SE, Abramson DH, (2010) Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma. Middle East African Journal of Ophthalmology 17: 207-209.
11. Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH, (2011) Intra-arterial chemotherapy for the management of retinoblastoma. Four-year experience. Arch Ophthalmol 129: 732-737.
12. Graeber CP, Gobin YP, Marr BP, Dunkel IJ, Brodie SE, et al. (2011) Histopathological findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. The open Ophthalmol Journal 5: 1-5.
13. Yamane T, Kaneko A, Mohri M, (2004) The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 9: 69-73.
14. Venturi C, Bracco S, Cerase A, Cioni S, Galluzzi P, et al. (2012) Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Acta Ophthalmol doi: 10.1111/j.1755-3768.2011.02296.x.
15. Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, et al. (2012) Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Ophthalmology 119: 611-616.
16. Shields CL, Bianciotto CG, Jabbour P, Ramasubramian A, Lally SE, et al. (2011) Intra-arterial chemotherapy for retinoblastoma. Report 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol 129: 1399-1406.
17. Peterson EC, Elhammady MS, Qintero-Wolfe S, Murray TG, Aziz-Sultan MA, (2011) Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg 114: 1603-1608.
18. Munier FL, Beck-Popovic M, Balmer A, Gaillard MC, Bovey E, et al. (2011) Occurrence of sectorial choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina 31: 566-573.
19. Abramson DH, Du TT, Beaverson KL, (2002) (Neonatal) Retinoblastoma in the first month of life. Arch Ophthalmol 120: 738-742.
20. Gombos DS, Kelly A, Coen PG, Kingston JE, Hungerford JL, (2002) Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age. Br J Ophthalmol 86: 80-83.
21. Dunkel IJ, Lee TC, Shi W, Beaverson KL, Novetsky DN, et al. (2007) A Phase II trial of carboplatin for intraocular retinoblastoma. Pediatr Blood Cancer 49: 643-648.
22. Lambert MP, Shields CL, Meadows AT, (2008) A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Pediatr Blood Cancer 50: 223-226.
23. Gombos DS, Hungerford JL, Abramson DH, Kingston J, Chantada GL, et al. (2007) Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology 114: 1378-1383.
24. Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, et al. (2006) Treatment of retinoblastoma patients with chemoreduction plus local therapy: Experience of the AC Camargo hospital, Brazil. J Pediatr Hematol Oncol 28: 342-345.
25. Rizzuti AE, Dunkel IJ, Abramson DH, (2008) The adverse events of chemotherapy for retinoblastoma: what are they? Do we know? Arch Ophthalmol 126: 862-865.
26. Cohen VM, Kingston J, Hungerford JL, (2009) The success of primary chemotherapy for group D heritable retinoblastoma. Br J Ophthalmol 93: 887-890.